Both in Pharmaceuticals
Definium Therapeutics vs Erasca
Over the past year DFTX returned +148.4% and ERAS returned +48.6%; their daily moves had a correlation of 0.24.
DFTX +148.4% ERAS +48.6%Growth of $1, one year, split-adjusted
| Metric | DFTX | ERAS |
|---|---|---|
| Price | $38.21 | $14.21 |
| Market cap | $5.13B | $4.97B |
| Today | −0.52% | +0.57% |
| 1 month | −6.8% | −21.2% |
| 6 months | +118.3% | −4.9% |
| Year to date | — | +282.0% |
| 1 year | — | +583.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.05B | $268.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.7% | 60.0% |
| Short % of float | 11.0% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).